 |
|
|
|
|
Looking for the right candidate? Try our free job posting trial
New Jersey Life Science Industry Directory
Target your advertising by state, region or nationwide for the same low rate
Banner Advertising | Event Advertising
ContraVir Pharmaceuticals, Inc.
| | | | | Phone: | (732) 902-4000 | | Fax: | (732) 902-4100 | | Year Established: | 2013 | | Ticker: | CTRV | | Exchange: | NASDAQ | | Main Contact: | Patricia Nasshorn, Business Development | | | | Other Contacts: | Robert Foster, CEO
Theresa Matkovits, Ph.D., COO
John Cavan, CFO
Robert Foster, B.Sc. (Pharm), Pharm.D., Ph.D., CSO
Gary S. Jacob, Ph.D., Chairman
| | | | Company Description | | ContraVir is a biopharmaceutical company focused on the discovery and development of targeted antiviral therapies. ContraVir’s lead candidate, FV-100, is an orally available nucleoside analogue prodrug that is being developed for the treatment of herpes zoster, or shingles, which is an infection caused by the reactivation of varicella zoster virus (VZV). | |
|
|
|
|
|
|
|
